Regeneron Pharmaceuticals Inc (REGN) is trading at $827.72 down 1.87% over the past 24 hours. Its Galaxy Score is 30.9, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 6.8K engagements and 15 posts with 99% positive social sentiment.
AI summary: Regeneron Pharmaceuticals (REGN) is a biotech stock driven by Ebola momentum, rare disease drug approvals, and concerns over upcoming melanoma trial results. Price is near 52-week highs with a slight pullback (-0.84% 24h), supported by FDA approval and social enthusiasm, but weighed down by melanoma readouts.